Suppr超能文献

相似文献

1
Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation.
Cell Host Microbe. 2009 Dec 17;6(6):513-22. doi: 10.1016/j.chom.2009.11.004.
2
Hepatitis C and evasion of the interferon system: a PKR paradigm.
Cell Host Microbe. 2009 Dec 17;6(6):495-7. doi: 10.1016/j.chom.2009.11.009.
4
PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control.
Virus Res. 2009 Jun;142(1-2):51-6. doi: 10.1016/j.virusres.2009.01.007. Epub 2009 Feb 2.
7
Translational insensitivity to potent activation of PKR by HCV IRES RNA.
Antiviral Res. 2009 Sep;83(3):228-37. doi: 10.1016/j.antiviral.2009.05.004. Epub 2009 May 23.
8
Hepatitis C virus controls interferon production through PKR activation.
PLoS One. 2010 May 11;5(5):e10575. doi: 10.1371/journal.pone.0010575.
9
PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone.
J Virol. 2002 Nov;76(21):10637-53. doi: 10.1128/jvi.76.21.10637-10653.2002.
10
Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Infect Genet Evol. 2013 Oct;19:113-9. doi: 10.1016/j.meegid.2013.06.025. Epub 2013 Jul 5.

引用本文的文献

1
IFN alpha inducible protein 27 (IFI27) acts as a positive regulator of PACT-dependent PKR activation after RNA virus infections.
PLoS Pathog. 2025 Jun 16;21(6):e1013246. doi: 10.1371/journal.ppat.1013246. eCollection 2025 Jun.
2
The Seneca Valley virus 3C protease cleaves DCP1A to attenuate its antiviral effects.
Vet Res. 2025 Feb 28;56(1):46. doi: 10.1186/s13567-025-01477-0.
4
RNA editing in response to COVID-19 vaccines: unveiling dynamic epigenetic regulation of host immunity.
Front Immunol. 2024 Sep 6;15:1413704. doi: 10.3389/fimmu.2024.1413704. eCollection 2024.
5
Epigenetic Restriction Factors (eRFs) in Virus Infection.
Viruses. 2024 Jan 25;16(2):183. doi: 10.3390/v16020183.
6
HCV-induced autophagy and innate immunity.
Front Immunol. 2024 Feb 2;15:1305157. doi: 10.3389/fimmu.2024.1305157. eCollection 2024.

本文引用的文献

1
Translational insensitivity to potent activation of PKR by HCV IRES RNA.
Antiviral Res. 2009 Sep;83(3):228-37. doi: 10.1016/j.antiviral.2009.05.004. Epub 2009 May 23.
2
PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control.
Virus Res. 2009 Jun;142(1-2):51-6. doi: 10.1016/j.virusres.2009.01.007. Epub 2009 Feb 2.
4
Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2.
Nat Struct Mol Biol. 2008 Aug;15(8):836-41. doi: 10.1038/nsmb.1445. Epub 2008 Jul 6.
5
Old and emerging therapies in chronic hepatitis C: an update.
J Viral Hepat. 2008 Jan;15(1):2-11. doi: 10.1111/j.1365-2893.2007.00887.x.
6
Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion.
J Virol. 2008 Mar;82(5):2120-9. doi: 10.1128/JVI.02053-07. Epub 2007 Dec 12.
7
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.
J Biol Chem. 2007 Nov 2;282(44):32357-69. doi: 10.1074/jbc.M705358200. Epub 2007 Aug 30.
9
Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
Dig Dis Sci. 2007 Jun;52(6):1540-7. doi: 10.1007/s10620-007-9757-9. Epub 2007 Apr 4.
10
Viral determinants of resistance to treatment in patients with hepatitis C.
Clin Microbiol Rev. 2007 Jan;20(1):23-38. doi: 10.1128/CMR.00010-06.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验